Factor V Leiden and hepatic artery thrombosis after liver transplantation

Clinical Transplantation

Volumn 20, Issue 1, 2006, Pages 132-135

  Dunn, Ty B ^a   Linden, Michael A ^a   Vercellotti, Gregory M ^a   Gruessner, Rainer W G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cost; Hepatic artery; Prophylaxis; Surgical complications; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTERY THROMBOSIS; ARTICLE; CADAVER DONOR; CASE REPORT; DISEASE COURSE; HEMOCHROMATOSIS; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; LIVER ABSCESS; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PERCUTANEOUS DRAINAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REOPERATION; SEPSIS; THROMBOPHILIA;

ACTIVATED PROTEIN C RESISTANCE; ALGORITHMS; FACTOR V; HEPATIC ARTERY; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POINT MUTATION; REOPERATION; THROMBOSIS;

EID: 33644812921     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00432.x     Document Type: Article

References (23)

1. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995: 346: 1133.
2. Bauer KA, Rosendaal FR, Heit JA. Hypercoagulability: Too many tests, too much conflicting data. Hematology (Am Soc Hematol Educ Program) 2002: 353.
3. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995: 85: 1504.
4. Bertina RM, Koeleman BP, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994: 369: 64.
5. Zoller B, Hillarp A, Berntorp E, Dahlback B. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis. Annu Rev Med 1997: 48: 45.
6. Larsen TB, Ravn HB, Lassen JF, Lund ED, Brandslund I. Resistance to activated protein C. The most common cause of familial thrombophilia. Ugeskr Laeger 1996: 158: 6584.
7. Settmacher U, Stange B, Haase R et al. Arterial complications after liver transplantation. Transpl Int 2000: 13: 372.
8. Urbani L, Catalano G, Biancofiore G et al. Surgical complications after liver transplantation. Minerva Chir 2003: 58: 675.
9. Rela M, Muiesan P, Bhatnagar V et al. Hepatic artery thrombosis after liver transplantation in children under 5 years of age. Transplantation 1996: 61: 1355.
10. Mas VR, Fisher RA, Maluf DG, Wilkinson DS, Garrett CT, Ferreira-Gonzalez A. Hepatic artery thrombosis after liver transplantation and genetic factors: Prothrombin G20210A polymorphism. Transplantation 2003: 76: 247.
11. Said A, Safdar N, Lucey MR et al. Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant 2004: 4: 574.
12. Taylor MC, Greig PD, Detsky AS, McLeod RS, Abdoh A, Krahn MD. Factors associated with the high cost of liver transplantation in adults. Can J Surg 2002: 45: 425.
13. Brown RS Jr, Ascher NL, Lake JR et al. The impact of surgical complications after liver transplantation on resource utilization. Arch Surg 1997: 132: 1098.
14. Whiting JF, Martin J, Zavala E, Hanto D. The influence of clinical variables on hospital costs after orthotopic liver transplantation. Surgery 1999: 125: 217.
15. Foster PA, Varma RR. Phenotypic correction of activated protein C resistance following orthotopic liver transplantation. Blood Coagul Fibrinolysis 1996: 7: 65.
16. Schuetze SM, Linenberger M. Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplant. Transplantation 1999: 67: 1366.
17. Leroy-Matheron C, Duvoux C, Van Nhieu JT, Leroy K, Cherqui D, Gouault-Heilmann M. Activated protein C resistance acquired through liver transplantation and associated with recurrent venous thrombosis. J Hepatol 2003: 38: 866.
18. Karasu Z, Nart D, Lebe E et al. Liver transplantation in a patient with Budd-Chiari syndrome secondary to factor V Leiden mutation. Transplant Proc 2003: 35: 3008.
19. Bontempo FA, Hassett AC, Faruki H, Steed DL, Webster MW, Makaroun MS. The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation. J Vasc Surg 1997: 25: 271; discussion: 276.
20. Eskandari MK, Bontempo FA, Hassett AC, Faruki H, Makaroun MS. Arterial thromboembolic events in patients with the factor V Leiden mutation. Am J Surg 1998: 176: 122.
21. Moor E, Silveira A, van't Hooft F et al. Coagulation factor V (Arg506->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting. Thromb Haemost 1998: 80: 220.
22. Hirshfield G, Collier JD, Brown K et al. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg 1998: 4: 58.
23. Christella M, Thomassen LG, Castoldi E et al. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool. Haematologica 2003: 88: 1150.